Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene Gel + NBUVB for Psoriasis
NCT00151008Phase 2Completed
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Nov 2003
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, double-blind trial in Psoriasis vulgaris (PV) comparing Bexarotene Side with Vehicle Side (2 arms). Primary endpoint: Mean decrease in target lesion size at 10 weeks. Started Nov 2003; status: completed.
02
Drugs
bexarotene
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00151008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151008.